TrialScope has announced two executive appointments. Brian Flaherty will be vice-president of Business Development and Thomas Wicks has been appointed chief strategy officer (CSO).
Brian Flaherty joins the TrialScope team with 19 years of sales experience including ten years of sales within the life sciences industry.
Mr Flaherty was global executive director of Sales at Covance Clinical. In his new role, Mr Flaherty will lead TrialScope’s sales efforts, including account management and new business development.
Thomas Wicks was promoted to CSO from his current position of chief operating officer. Mr Wicks brings more than 17 years of experience working with performance and content management solutions.
He previously served as general manager of PharmaCM at Deloitte and as the director of PharmaCM Product Management at Intrasphere Technologies.
In his new role, Mr Wicks will be responsible for liaising with industry leaders, developing TrialScope’s response to emerging trends and regulatory mandates, and championing the company’s strategic vision in the marketplace.
TrialScope CEO Mike Forgash said: "Thomas has continued to be a driving force in developing our corporate and product strategy and his new position will enable him to focus more fully on this area."
"We’ll look to Brian to leverage his experience to lead our sales efforts, expand our client base and continue to create a world-class customer experience for our life sciences customers."